Home/Hedge Fund Intelligence/Dyne Therapeutics, Inc.
Nasdaq: DYNStockForm 13F30 Jun 2026

Hedge funds that hold Dyne Therapeutics, Inc. Nasdaq: DYN

CUSIP 26818M108 · who reports it, how much, and how much it matters to them

35 of the 720 hedge fund managers we track reported shares of Dyne Therapeutics, Inc. (Nasdaq: DYN) on Form 13F for 30 June 2026. Between them they reported USD 627m. The largest position belongs to Orbimed Advisors, at USD 72m. The manager with the most riding on it is Palo Alto Investors, where it is 5.1% of the reported book.

Managers reporting it35of 720 we track
Value they reportUSD 627mshares only, 30 Jun 2026
Funds they run407with a file on PPLI.com
Largest positionUSD 72mOrbimed Advisors
Typical weight0.1%median share of a manager's book
Heaviest weight5.1%Palo Alto Investors

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

35 managers, USD 627m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Dyne Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Orbimed Advisors1 fund on PPLI.comUSD 72m1.3%
2Armistice Capital1 fund on PPLI.comUSD 69m0.8%
3Perceptive Advisors6 funds on PPLI.comUSD 60m0.9%
4Logos Global Management1 fund on PPLI.comUSD 57m2.4%
5Samlyn Capital8 funds on PPLI.comUSD 39m0.6%
6Sofinnova Investments1 fund on PPLI.comUSD 37m1.9%
7Palo Alto Investors6 funds on PPLI.comUSD 37m5.1%
8Deep Track Capital1 fund on PPLI.comUSD 33m0.5%
9Marshall Wace LLP84 funds on PPLI.comUSD 33m0.0%
10Polar Capital LLP26 funds on PPLI.comUSD 29m0.1%
11Citadel Advisors32 funds on PPLI.comUSD 25m0.0%
12Rock Springs Capital Management2 funds on PPLI.comUSD 21m1.0%
13Braidwell12 funds on PPLI.comUSD 20m0.8%
14Baker Bros. Advisors2 funds on PPLI.comUSD 18m0.1%
15Artisan Partners1 fund on PPLI.comUSD 15m0.0%
16Millennium Management6 funds on PPLI.comUSD 9.6m0.0%
17Arrowmark Colorado Holdings24 funds on PPLI.comUSD 8.8m0.4%
18Renaissance Technologies13 funds on PPLI.comUSD 8m0.0%
19Moore Capital Management7 funds on PPLI.comUSD 6.8m0.1%
20Squarepoint Ops7 funds on PPLI.comUSD 6.7m0.0%
21Sphera Funds Management1 fund on PPLI.comUSD 4.4m0.6%
22HighVista Strategies27 funds on PPLI.comUSD 3.8m0.9%
23Adage Capital Management1 fund on PPLI.comUSD 3.3m0.0%
24Schonfeld Strategic Advisors30 funds on PPLI.comUSD 3m0.0%
25Jain Global1 fund on PPLI.comUSD 2.6m0.0%
26D. E. Shaw & Co.15 funds on PPLI.comUSD 1.3m0.0%
27Mangrove Partners Im1 fund on PPLI.comUSD 1.1m0.1%
28Atom Investors1 fund on PPLI.comUSD 957,0000.1%
29Brevan Howard Capital Management39 funds on PPLI.comUSD 827,0000.0%
30Neo Ivy Capital Management1 fund on PPLI.comUSD 698,0000.2%
31Boothbay Fund Management2 funds on PPLI.comUSD 680,0000.0%
32Lion Point Capital1 fund on PPLI.comUSD 400,0001.9%
33Two Sigma Investments35 funds on PPLI.comUSD 315,0000.0%
34Persistent Asset Partners10 funds on PPLI.comUSD 124,0000.0%
35The Quarry1 fund on PPLI.comUSD 5770.0%
Next: where it matters most
Where it matters most

For Palo Alto Investors it is 5.1% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Palo Alto InvestorsUSD 37m5.1%
2Logos Global ManagementUSD 57m2.4%
3Lion Point CapitalUSD 400,0001.9%
4Sofinnova InvestmentsUSD 37m1.9%
5Orbimed AdvisorsUSD 72m1.3%
6Rock Springs Capital ManagementUSD 21m1.0%
7Perceptive AdvisorsUSD 60m0.9%
8HighVista StrategiesUSD 3.8m0.9%
9Armistice CapitalUSD 69m0.8%
10BraidwellUSD 20m0.8%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Dyne Therapeutics, Inc.

What is the ticker symbol of Dyne Therapeutics, Inc.?

Dyne Therapeutics, Inc. trades under the symbol DYN on the Nasdaq. Its CUSIP, the code used on Form 13F, is 26818M108.

Which hedge funds own Dyne Therapeutics, Inc. (Nasdaq: DYN)?

35 of the 720 hedge fund managers PPLI.com tracks reported Dyne Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Orbimed Advisors (USD 72m), Armistice Capital (USD 69m), Perceptive Advisors (USD 60m), Logos Global Management (USD 57m) and Samlyn Capital (USD 39m).

How many hedge funds hold Dyne Therapeutics, Inc.?

35 managers in our coverage reported it, and between them they run 407 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Dyne Therapeutics, Inc.?

Palo Alto Investors, where the position was 5.1% of the reported 13F book at 30 June 2026.

Does this show who is short Dyne Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Dyne Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.